<rdf:RDF xmlns:crm='http://www.cidoc-crm.org/rdfs/cidoc_crm_v5.0.2_english_label.rdfs#' xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:dcterms='http://purl.org/dc/terms/' xmlns:doap='http://usefulinc.com/ns/doap#' xmlns:edm='http://www.europeana.eu/schemas/edm/' xmlns:ekt='https://www.semantics.gr/authorities/schemanamespaces/ekt#' xmlns:foaf='http://xmlns.com/foaf/0.1/' xmlns:ore='http://www.openarchives.org/ore/terms/' xmlns:owl='http://www.w3.org/2002/07/owl#' xmlns:rdaGr2='http://rdvocab.info/ElementsGr2/' xmlns:rdf='http://www.w3.org/1999/02/22-rdf-syntax-ns#' xmlns:rdfs='http://www.w3.org/2000/01/rdf-schema#' xmlns:skos='http://www.w3.org/2004/02/skos/core#' xmlns:svcs='http://rdfs.org/sioc/services#' xmlns:wgs84_pos='http://www.w3.org/2003/01/geo/wgs84_pos#' xmlns:xalan='http://xml.apache.org/xalan'><edm:ProvidedCHO rdf:about='https://www.openarchives.gr/aggregator-openarchives/edm/gastro/000025-104'><dc:creator>Tsianos E.V.,</dc:creator><dc:creator>Katsanos K.,</dc:creator><dc:description xml:lang='en'>SUMMARY
Few reports concerning the levels and the importance of
insulin-like growth factors (IGFs) and IGF binding proteins
(IGFBPs) in the serum of patients with inflammatory
bowel disease (IBD) have been published.
Insulin-like growth factor(IGF) system has properties that
are potentially relevant to IBD. The IGF system is a system
complex composed of IGF-I and IGF-II as well as at least
six different IGF binding proteins (IGFBP).IGF-I expression
has been shown in lymphocytes, macrophages and fibroblasts.
IGF-I is a potent mitogen for fibroblasts and
smooth muscle cells and induces collagen synthesis in vitro,
appearing to be important in tissue remodeling and repair.
Proinflammatory cytokines such as interleukin-1 (IL-
1) may play a role in IGF-I production linking the IGF system
with the inflammatory process in IBD patients. It has
been suggested that IBD patients may have low IGF-I and
IGFBP levels. In recent years the effect of regulatory peptides
such as growth hormone (GH) and IGF-I in intestinal
growth and repair has been emphasized. Trials of growth
hormone in combination with a high-protein diet in short
bowel syndrome patients as well as Crohns disease (CD)
patients have been encouraging. It has been suggested that
the IGF and IGFBP system may be abnormal in IBD patients
during this chronic inflammatory process, yet there
is no data is on the exact impact of inflammation on this
down-regulation and the interaction between the interleukins
and the IGF and IGFBP system, in IBD patients. Key words: IGF system, IGF-I, IGF-II, IGFBP3, IGFBP,
inflammatory bowel disease (IBD), Crohns disease (CD),
ulcerative colitis (UC).</dc:description><dc:format>application/pdf</dc:format><dc:identifier>http://www.annalsgastro.gr/index.php/annalsgastro/article/view/104</dc:identifier><dc:language>eng</dc:language><dc:publisher xml:lang='en'>Hellenic Society of Gastroenterology</dc:publisher><dc:relation rdf:resource='http://www.annalsgastro.gr/index.php/annalsgastro/article/view/104/91'></dc:relation><dc:source>1792-7463</dc:source><dc:source>1108-7471</dc:source><dc:source xml:lang='en'>Annals of Gastroenterology; Volume 15, No 1 (2002)</dc:source><dc:subject rdf:resource='http://semantics.gr/authorities/EKT-voc-classifier/657834409'></dc:subject><dc:title xml:lang='en'>Insulin-like growth factor system and inflammatory bowel disease</dc:title><dc:type rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Journal-part'></dc:type><dc:type>info:eu-repo/semantics/article</dc:type><dc:type>info:eu-repo/semantics/publishedVersion</dc:type><dc:type rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Report'></dc:type><dcterms:created>2007-03-19</dcterms:created></edm:ProvidedCHO><skos:Concept rdf:about='http://semantics.gr/authorities/openarchives-item-types/Journal-part'><skos:prefLabel xml:lang='el'>Δημοσίευση σε περιοδικό</skos:prefLabel><skos:prefLabel xml:lang='en'>Publication in journal</skos:prefLabel><skos:broader rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Issue-segment'></skos:broader></skos:Concept><skos:Concept rdf:about='http://semantics.gr/authorities/EKT-voc-classifier/657834409'><skos:prefLabel xml:lang='el'>Γαστροεντερολογία</skos:prefLabel><skos:prefLabel xml:lang='en'>Gastroenterology</skos:prefLabel><skos:broader rdf:resource='http://semantics.gr/authorities/EKT-voc-classifier/1368266523'></skos:broader><skos:exactMatch rdf:resource='http://semantics.gr/authorities/EKT-voc/657834409'></skos:exactMatch><skos:exactMatch rdf:resource='http://id.loc.gov/authorities/subjects/sh85053479'></skos:exactMatch><skos:note xml:lang='en'>isi -Gastroenterology &amp; Hepatology covers resources on the anatomy, physiology, biochemistry, and pathology of the digestive system. This category includes specific resources on the prognosis and treatment of digestive diseases; stomach ulcers; metabolic, genetic, infectious and chemically induced diseases of the liver; colitis; diseases of the pancreas and diseases of the rectum.</skos:note></skos:Concept><skos:Concept rdf:about='http://semantics.gr/authorities/openarchives-item-types/Report'><skos:prefLabel xml:lang='el'>Αναφορά</skos:prefLabel><skos:prefLabel xml:lang='en'>Report</skos:prefLabel><skos:narrower rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Technical-Report'></skos:narrower><skos:exactMatch rdf:resource='http://vocab.getty.edu/aat/300027267'></skos:exactMatch></skos:Concept><ore:Aggregation rdf:about='https://www.openarchives.gr/aggregator-openarchives/edm/aggregation/provider/000025-104%231'><edm:aggregatedCHO rdf:resource='https://www.openarchives.gr/aggregator-openarchives/edm/gastro/000025-104'></edm:aggregatedCHO><edm:dataProvider>Ελληνική Γαστροεντερολογική Εταιρία</edm:dataProvider><edm:isShownAt rdf:resource='http://www.annalsgastro.gr/index.php/annalsgastro/article/view/104'></edm:isShownAt><edm:provider>Greek Aggregator OpenArchives.gr | National Documentation Centre (EKT)</edm:provider><edm:rights>other</edm:rights></ore:Aggregation></rdf:RDF>